Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

Giovanni Ostuzzi¹, Davide Papola², Chiara Gastaldon², Georgios Schoretsanitis³, Federico Bertolini², Francesco Amaddeo², Alessandro Cuomo⁴, Robin Emsley⁵, Andrea Fagiolini⁴, Giuseppe Imperadore⁶, Taishiro Kishimoto⁷, Giulia Michencigh², Michela Nosé², Marianna Purgato², Serdar Dursun⁸, Brendon Stubbs^{9

10}, David Taylor¹¹, Graham Thornicroft¹², Philip B Ward¹³, Christoph Hiemke¹⁴, Christoph U Correll^{3

15

16}, Corrado Barbui²

Affiliations

¹ WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy. giovanni.ostuzzi@univr.it.
² WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
³ Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.
⁴ Department of Molecular Medicine, University of Siena, Siena, Italy.
⁵ Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg Campus, Cape Town, 8000, South Africa.
⁶ Azienda ULSS 9 Scaligera, Verona, Italy.
⁷ Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
⁸ Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada.
⁹ Department of Psychological Medicine, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
¹⁰ Physiotherapy Department, South London and Maudsley National Health Services Foundation Trust, London, UK.
¹¹ Pharmacy Department, Maudsley Hospital, London, UK.
¹² Centre for Global Mental Health and Centre for Implementation Science, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
¹³ School of Psychiatry, UNSW Sydney and Schizophrenia Research Unit, Ingham Institute of Applied Medical Research, Liverpool, NSW, Australia.
¹⁴ Department of Psychiatry and Psychotherapy, University Medical Center of Mainz, Mainz, Germany.
¹⁵ Department of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
¹⁶ Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin Berlin, Berlin, Germany.

PMID: 32919477
PMCID: PMC7486584
DOI: 10.1186/s12916-020-01757-w

Published Erratum

Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

Giovanni Ostuzzi et al. BMC Med. 2020.

. 2020 Sep 12;18(1):291.

doi: 10.1186/s12916-020-01757-w.

Authors

Affiliations

¹ WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy. giovanni.ostuzzi@univr.it.
² WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
³ Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.
⁴ Department of Molecular Medicine, University of Siena, Siena, Italy.
⁵ Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg Campus, Cape Town, 8000, South Africa.
⁶ Azienda ULSS 9 Scaligera, Verona, Italy.
⁷ Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
⁸ Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada.
⁹ Department of Psychological Medicine, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
¹⁰ Physiotherapy Department, South London and Maudsley National Health Services Foundation Trust, London, UK.
¹¹ Pharmacy Department, Maudsley Hospital, London, UK.
¹² Centre for Global Mental Health and Centre for Implementation Science, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
¹³ School of Psychiatry, UNSW Sydney and Schizophrenia Research Unit, Ingham Institute of Applied Medical Research, Liverpool, NSW, Australia.
¹⁴ Department of Psychiatry and Psychotherapy, University Medical Center of Mainz, Mainz, Germany.
¹⁵ Department of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
¹⁶ Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin Berlin, Berlin, Germany.

PMID: 32919477
PMCID: PMC7486584
DOI: 10.1186/s12916-020-01757-w

Abstract

An amendment to this paper has been published and can be accessed via the original article.

PubMed Disclaimer

Erratum for

Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.
Ostuzzi G, Papola D, Gastaldon C, Schoretsanitis G, Bertolini F, Amaddeo F, Cuomo A, Emsley R, Fagiolini A, Imperadore G, Kishimoto T, Michencigh G, Nosé M, Purgato M, Dursun S, Stubbs B, Taylor D, Thornicroft G, Ward PB, Hiemke C, Correll CU, Barbui C. Ostuzzi G, et al. BMC Med. 2020 Jul 15;18(1):215. doi: 10.1186/s12916-020-01685-9. BMC Med. 2020. PMID: 32664944 Free PMC article. Review.

References

1. Ostuzzi, et al. Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations. BMC Medicine. 2020;18:215. doi: 10.1186/s12916-020-01685-9. - DOI - PMC - PubMed

Publication types

Actions

Grants and funding

MR/S001255/1/MRC_/Medical Research Council/United Kingdom

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

Affiliations

Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

Authors

Affiliations

Abstract

Erratum for

References

Publication types

Grants and funding